All clinical investigations requiring authorisation by CA
Legal representative domiciled in the EU/EEA
Declaration of the end of the trial form (en) / Meldeformular für die Beendigung der Klinischen Prüfung (de)
L I206 Leitfaden KP Einreichung (de) / L I209 Guidance CT submission (en)
Art 32(1) AMG
Alternative declaration: Informal communication of the National End of Trial in addition to the subsequent reporting of the global End of Trial: In this case, the procedure is closed with the National End of Trial and only the provisions for the final study report remain.